Anavex Life Sciences Corporation (AVXL)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt AVXL? Forum Prognose Aktiensplit

Finanzdaten der Anavex Life Sciences Corporation-Aktie (AVXL)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	11.16% 1.075	1.21	1.394	1.759	1.796
Operating Expenses	15.55% 14.46	12.51	13.59	14.34	14.73
Benefits Costs and Expenses	-	-	-	13.50	14.08
Costs And Expenses	13.20% 15.53	13.72	14.99	13.50	14.08
Provision For Loan, Lease, And Other Losses	-	-	-	-	-
Operating Income/Loss	15.55% -14.46	-12.51	-13.59	-14.34	-14.73
Net Interest Income/Expense	11.16% 1.075	1.21	1.394	1.759	1.796
Nonoperating Income/Loss	7.67% 1.216	1.317	1.481	2.592	2.448
Income/Loss From Continuing Operations Before Tax	11.16% 1.075	1.21	1.394	-11.74	-12.28
Income/Loss From Continuing Operations After Tax	18.28% -13.24	-11.20	-12.11	-11.62	-12.21
Net Income/Loss	18.28% -13.24	-11.20	-12.11	-11.62	-12.21
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	0.36% 85.38	85.07	84.81	0.4457	84.54
Diluted Average Shares	0.36% 85.38	85.07	84.81	0.4457	84.54
Basic Earnings Per Share	23.08% -0.16	-0.13	-0.14	-0.14	-0.14
Diluted Earnings Per Share	23.08% -0.16	-0.13	-0.14	-0.14	-0.14
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

RPRX

$37.30

0.64%

GMAB

$28.71

0.35%

INCY

$101.57

8.65%

BNTX

$103.95

0.04%

ONC

$311.86

0.44%

INSM

$186.23

1.78%